As day two of the MoneyShow conference in Toronto reached its midpoint, expert panelists gave investors their input on the future of the Canadian marijuana market.

The panel consisted of Cam Battley, chief corporate officer at Aurora Cannabis (TSX:ACB); Danny Brody, vice president of investor relations at Green Organic Dutchman Holdings (TSX:TGOD); Mark Noble, senior vice president and head of sales strategy at Horizons ETFs; and Chris Wagner, CEO at Emerald Health Therapeutics (TSXV:EMH).


Moderated by Jay Rosenthal, co-founder and president of Business of Cannabis, the discussion started out with a question about whether Canada’s impending October 17 recreational cannabis legalization date will be a legitimate game changer, or merely a milestone.

 

Cannabis - Will The Fortune 500 Join The Party?

 
Our Exclusive FREE Report Contains Information You NEED To Know About Cannabis Stock Investing!
 

Wagner said that depending on which side of the industry you’re on, it will likely be both.

“It’s not the dawn of a new era for Canadians socially and for our society … but it’s probably the dawn of a new era corporately and for Canadian companies,” he said.

“We will all remember this time as a time when large, dominant Canadian firms in this space started, and we have such a huge head start over anybody else on the planet that this will be remembered as the start of a brand-new industry that will be, and already is, global and that Canadians are leading.”

Rosenthal asked the panelists to describe their perception on the timeline for the industry as it relates to investors. Comparing it to tech updates, the participants were asked to answer whether legalization represents version 1.0 or 2.0.

Wagner said he believes the market is at version 0.01, saying it “[isn’t] even the first chapter.”

Battley said Canada’s upcoming legalization will provide a major window of opportunity for Canadian companies to become prominent on a global scale.

“It’s going to be a multibillion-dollar business in Canada. That’s great, but that’s not a global industry, that doesn’t get us into the realm of brewers and distillers,” he said.

Battley told the audience a change in US policy could happen quickly. “When that happens, there will be large, well-capitalized US competitors.”

 

Cannabis - Will The Fortune 500 Join The Party?

 
Our Exclusive FREE Report Contains Information You NEED To Know About Cannabis Stock Investing!
 

Canadian producers such as Aphria (TSX:APH) and Cronos Group (TSX:CRON) have disclosed intentions to move into the US market once the drug becomes legal on the federal level.

“We have that window of opportunity to establish our global infrastructure and the networks and the distribution and the local production, all the things that we need, and we [have to] do it fast, because that’s the major economic opportunity.”

The Aurora executive finished his point by saying that companies at the forefront of global expansion are the ones most likely to maintain their market stance and stay relevant in the coming years.

“If you’re looking out three, five years and you want to see which companies are going to be around, look for the companies that are able to establish their global presence and succeed in selling into multiple global markets,” Battley said. “Those ones will be the ones that survive and thrive.”

Cannabis experts comment on infused product craze

The discussion then moved to the question of how each panelist’s company will be preparing for Canada’s additional shift to cannabis-infused food and drink products, set to be legalized separately sometime after October 17.

Noble took the opportunity to highlight how broad the cannabis market stands to become in the coming years, saying diversification is an essential component to success, both for investors and companies.

“When this becomes a consumer-driven industry, on both the medical and the recreational side, things like marketing, brand, product, features are all going to come into play,” he said. “Diversification is your friend here.”

 

Cannabis - Will The Fortune 500 Join The Party?

 
Our Exclusive FREE Report Contains Information You NEED To Know About Cannabis Stock Investing!
 

Noble explained the time is closing for companies with exorbitant valuations to sell promises and instead deliver results.

“I think that going into the new year, companies that are trading at above $10 billion on less than $50 million in revenue, that’s a disappointment waiting to happen,” Noble said.

The Horizons executive told the investor audience he expects some smaller companies to do well overall, and for some of the bigger cannabis ventures to become “extremely disappointing” on valuations.

He ended by explaining that putting all your eggs in one basket can be detrimental in the cannabis sector, and said that diversifying amongst companies that are strong brand leaders, acquisition targets or globally expanding will be an investor’s golden goose to “capture that full growth.”

One of the final questions was what the panelists consider the “sleeper stories” of the sector that will come to light in the next year. While Battley and Wagner both discussed hemp, Brody showed his enthusiasm for the medical market to further expand with legal research and development.

“I think that’s going to be a huge market,” he said.

Don’t forget to follow us @INN_Cannabis for real-time news updates and stay tuned for cannabis stories from the MoneyShow!

Securities Disclosure: I, Olivia Da Silva, hold no direct investment interest in any company mentioned in this article.

 

Cannabis - Will The Fortune 500 Join The Party?

 
Our Exclusive FREE Report Contains Information You NEED To Know About Cannabis Stock Investing!
 

Trulieve Cannabis Corp. (“Trulieve” or the “Company”) (CSE: TRUL) (OTCQX: TCNNF), a leading and top-performing cannabis company in the United States today announced the appointment of Marcum LLP (“Marcum”) as its independent registered public accounting firm, effective July 5, 2021 . Marcum was appointed following the resignation of MNP LLP (“MNP”) as the Company’s independent registered public accounting firm effective July 5, 2021 .

“We would like to thank MNP for their guidance and expertise over the past two years and we look forward to working with Marcum as the Company’s new independent registered public accounting firm,” stated Chief Financial Officer, Alex D’Amico.

Keep reading... Show less

Cannabis-infused beverages are not a new product concept, but this summer Canadian drink makers hope consumers will discover them for the first time.

Recreational cannabis beverages have beguiled Canadian producers through different avenues, and many continue to make investments. The promise of these drinks lies in the potential of a more welcoming option for new consumers who may be out of their depth with rolled-up dried flower.

Keep reading... Show less

In the news release, BioHarvest Sciences Inc.‘s First Cannabis Cell Reservoir Produces Ongoing Flowering Stage Cannabinoid Cells For 2 Years, issued 07-Jul-2021 by BioHarvest Sciences Inc. over PR Newswire, we are advised by the company that an incorrect version of the release was issued inadvertently. The complete, corrected release follows:

BioHarvest Sciences Inc.‘s First Cannabis Cell Reservoir Produces Ongoing Flowering Stage Cannabinoid Cells For 2 Years

Keep reading... Show less

Trulieve is the first medical cannabis operator to start planting in the state

Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company based in the United States announced today that it commenced operations in West Virginia . The Company has begun cultivation at their 100,000 square foot size facility in Huntington, West Virginia .

Keep reading... Show less

– The Company demonstrates the efficiency and reliability of its BioFarming technology by reducing production cycle time for Cannabis from 14-23 weeks to 3-4 weeks.

– The Company’s BioFarming technology will allow the Company to harvest 13-17 cycles per year versus 2-4 cycles per year for conventional Cannabis agriculture.

Keep reading... Show less